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Background In China, childhood asthma prevalence showed a remarkable increase in the past 
decades. An updated epidemiological assessment of childhood asthma in China with a focus 
on prevalence and time trends is required. 
Methods We systematically searched three main Chinese databases and one English database 
to identify epidemiological studies of the prevalence of childhood asthma in China. Asthma 
cases were defined according to one of the five sets of Chinese diagnostic criteria which were 
established by the Children Respiratory Disease Group. We estimated age- and sex-specific 
prevalence of asthma using a multilevel mixed-effects logistic regression. We presented the 
time trends of asthma prevalence between 1990 and 2020 by age, sex and setting (urban vs 
rural), and also estimated the number of children affected by asthma in 2010. 
Results In 1990, the prevalence of asthma ranged from 0.13% (95% confidence interval 
CI=0.10-0.20) in rural girls aged 14 years to 1.34% (95% CI=1.11-1.67) in urban boys aged 
five years. In 2010, the overall prevalence of asthma in Chinese children aged 0-14 years was 
2.12% (95% CI=1.83-2.51), corresponding to 5.16 million children living with asthma. 
Children aged 5-9 years were with the highest prevalence estimate of 2.65% (95% CI=2.31-
3.12) and those aged 10-14 years were with the lowest (1.48% [95% CI=1.26-1.78]). In 2020, 
it is expected that this disparity will continue, with the prevalence of asthma being at the lowest 
level among rural girls aged 14 years (1.11% [95% CI=0.82-1.54)] and at the highest level 
among urban boys aged four years (10.27% [95% CI=8.61-12.18]). Over the 30 years (1990-
2020), the prevalence of asthma in children aged 0-14 years has increased in both sexes and 
settings, which was consistently the lowest in rural girls and the highest in urban boys. 
Conclusions This study shows that childhood asthma has been increasingly prevalent in China. 
Asthma is more frequent in boys and in rural areas. The detailed and systematic estimates of 




planning, and allocation of health and welfare resources related to the burden of childhood 
asthma in China. 
Asthma is defined as a chronic inflammatory disorder of airways and is associated with airway 
hyper-responsiveness that leads to attacks of wheezing, breathlessness, cough and/or chest 
tightness with varying severity and frequency [1]. Globally, asthma has been recognized one 
of the most costly respiratory disorders, which has caused substantial disability, impaired 
quality of life and deaths among children and young adults [2]. The Global Burden of Disease 
Study (GBD) in 2015 estimated that asthma accounts for 1.1% of the overall global estimates 
of disability-adjusted life years lost [3]. Approximate one third to half of children with 
moderate to severe asthma may persist to adulthood, which has exerted heavy burden on family 
and healthcare system [4]. Importantly, a substantial increase in the prevalence of childhood 
asthma has been reported across the world [5]. The most striking increase was observed in 
westernized countries, such as the United Kingdom, Australia, and Canada, which already had 
high rates of reported asthma, and a significant increase has also been noted in Asia and Eastern 
Europe which had a relative lower baseline prevalence [5]. With current rising trends, it is 
foreseeable that asthma will become a more serious public health problem and is of great 
concern among medical and health professionals. 
In China, childhood asthma prevalence showed a remarkable increase in the past decades. The 
Chinese national cooperative group conducted three sample surveys in 1990, 2000 and 2010 to 
assess the prevalence of asthma in children aged 0-14 years. The first survey in 1990 reported 
the prevalence of asthma ranging from 0.09 to 2.60% in urban-resident children with a national 
prevalence of 0.91% [6]. In 2000, the second survey showed that the prevalence of asthma had 
increased to 0.52-3.34%, with a national prevalence of 1.54% [7]. In 2010, the third repeated 
survey found that the prevalence was estimated to be 0.42-5.37% with a national prevalence of 
2.32% [8]. Since then, no recent official statistics have been made available on the current 
status of childhood asthma at the national level, though a multitude of new sub-national surveys 
have been conducted in different cities of China showing considerable regional variations [9-
11]. 
Given the availability of national and sub-national investigations in childhood asthma in China, 
it is possible for us to provide an up-to-date analysis of the prevalence rate of asthma among 
Chinese children. In this study, we conducted a systematic review and meta-analysis to 
investigate the prevalence of asthma in Chinese children aged 0-14 years. The time trends 
(1990-2020) and variations of asthma prevalence by age, sex and setting (urban vs. rural) were 
also explored. Moreover, the number of children affected by asthma in 2020 was also 
estimated. 
METHODS  
Systematic review and data extraction 
This systematic review and meta-analysis was conducted in accordance with the Preferred 




bibliographic databases, including China National Knowledge Infrastructure (CNKI), Wanfang 
Data and VIP Database for Chinese Technical Periodical (VIP) and PubMed, were searched on 
16th March 2019 to retrieve all epidemiological studies of asthma in Chinese children that were 
published from 1990 onwards. All titles, abstracts and keywords, followed by full texts of the 
records were examined by two independent trained reviewers (CNKI, Wanfang and VIP: XL, 
PS and HL; PubMed: XL and YZ) in parallel. Briefly, only studies that were conducted in the 
general paediatric population in Mainland China were included. The eligible studies should 
have reported the numerical prevalence of asthma in children, and asthma should be defined 
according to one of the five sets of Chinese diagnostic criteria which were established by the 
first Children Respiratory Disease Conference in 1987, the Nation Cooperation Group on 
Childhood Asthma (NCGCA) of 1993 or 1998, and the Branch for Respiratory Diseases of 
Chinese Medical Associations (BRDCMA) of 1997 or 2003 [13]. For multiple publications 
based on the same study, the one with the most detailed information was kept. 
All relevant data, including author(s), year of publication, study design, sampling method, 
setting (urban, rural or mixed), year of investigation, asthma diagnosis, sample size and asthma 
cases, were extracted from the included studies. Wherever prevalence was split into different 
subgroups, i.e., age-, sex-, setting-specific prevalence, data were tabulated for those subgroups 
accordingly. 
Statistical analysis 
In the data extraction procedure, individual studies were used to provide multiple data points 
which contributed to the overall dataset. To take into account the sample size and the 
availability of different data points from the same study, a multilevel mixed-effects logistic 
regression was adopted with a restricted cubic spline [14,15]. This was then used to model the 
asthma prevalence as a function of age. Based on a total of 752 data points, the age-, sex- and 
setting-specific prevalence of asthma in Chinese children was estimated for the years 1990, 
2000, 2010 and 2020. We further estimated the corresponding 95% confidence intervals (CIs) 
by applying the semiparametric bootstrapping method [16]. The number of asthma cases in 
Chinese children aged 14 years and younger in 2010 was calculated by multiplying the 
paediatric population size in China, available from the United Nations Population Division 
(UNPD) and the China Census 2010. All the analyses were conducted in R v3.3.0 
(https://www.r-project.org/). 
RESULTS 
Our literature search returned a total of 29,987 citations. After removing 25,014 duplicates and 
irrelevant citations, 4,973 records were screened, among which 1,026 were reviewed at full-
text. Finally, 222 articles were included according to the eligibility criteria. The process of 
study selection is documented in detail in Figure 1. Table 1 demonstrates the main 
characteristics of the remaining 222 articles, which were all cross-sectional in design and 
defined asthma according to one of the five Chinese diagnostic criteria. More than half of these 
articles were published in the most recent decade (n=112, 50.5%) and most of the studies were 




A total of 55 retained articles provided the prevalence of asthma for different age and sex 
subgroups. Across the age span from zero to 14 years, the relation between age and asthma 
prevalence based on all informative data points is demonstrated in Figure 2. Generally, the 
prevalence of asthma steadily increased with age before five years old, and then started to 
decrease until 14 years old. 
Age, sex, setting and study year were all significantly associated with asthma prevalence. The 
final formula generated from the multilevel mixed-effects logistic regression is shown below: 
ln(𝑜𝑑𝑑𝑠) = −147.519 + 0.071 ∗ 𝑦𝑒𝑎𝑟 − 0.503 ∗ 𝑠𝑒𝑥௚௜௥௟ + 0.757 ∗ 𝑠𝑒𝑡𝑡𝑖𝑖𝑛𝑔௨௥௕௔௡ + 0.300
∗ 𝑎𝑔𝑒1 − 0.939 ∗ 𝑎𝑔𝑒2 + 1.959 ∗ 𝑎𝑔𝑒3 − 1.074 ∗ 𝑎𝑔𝑒4 + 𝑢𝑖 
Where 
odds = p/(1-p), p indicates the prevalence of asthma 
year = calendar year  
𝑠𝑒𝑥𝑟௚௜௥௟ = 1 for girls and 0 for boys 
𝑠𝑒𝑡𝑡𝑖𝑖𝑛𝑔௨௥௕௔௡ = 1 for urban areas and 0 for rural areas 
age1 -age4 are variables created in the process of fitting cubic splines (knots: 0.5, 
4.0, 7.0, 10.0, and 13.5)  
ui = variance of the study-level random effect 
Based on the final formula, age-specific prevalence of asthma in Chinese children was 
calculated for different sexes, settings and the years 1990, 2000, 2010 and 2020 respectively 
(Figure 3 and Table S1 in the Online Supplementary Document). Over the 30 years (1990-
2020), the prevalence of asthma in children aged 0-14 years has increased in both sexes and 
settings, which was consistently the lowest in rural girls and the highest in urban boys. In 1990, 
the prevalence of asthma ranged from 0.13% (95% CI=0.10-0.20) in rural girls aged 14 years 
to 1.34% (95% CI=1.11-1.67) in urban boys aged five years. In 2020, this disparity will 
continue, with the prevalence of asthma being at the lowest level among rural girls aged 14 
years (1.11% [95% CI=0.82-1.54)] and at the highest level among urban boys aged four years 
(10.27% [95% CI=8.61-12.18]). 
After applying the estimates of age-, sex- and setting-specific prevalence of asthma on United 
Nations Population Division's demographic data and China Census data, the overall prevalence 
of asthma and number of affected cases in Chinese children aged under 5 years (0-4 years), 5-
9 years, 10-14 years and 0-14 years were calculated for the year 2010 (Table 2 and Figure S1 
in the Online Supplementary Document). Overall, the prevalence of asthma in Chinese 
children aged 0-14 years was 2.12% (95% CI=1.83-2.51) in 2010. Children aged 5-9 years 
were with the highest prevalence estimate of 2.65% (95% CI=2.31-3.12) and those aged 10-14 




cases, the total number of affected children aged 0-14 years was 5.16 million (95% CI=4.45-
6.09) in China in 2010, among whom those aged 5-9 years contributed the most cases (40.5%, 
2.09 million [95% CI=1.83-2.47]). In 2010, more than one third (39.5%) of the paediatric 
asthma cases were boys living in urban areas. 
DISCUSSION 
In this study, by systematically reviewing all published evidence of childhood asthma 
prevalence and applying strict inclusion and exclusion criteria, we present a comprehensive 
estimate of the pooled prevalence and epidemic characteristics of asthma in Chinese children, 
including its time trend, sex difference, age structures and the predicted prevalence in the 
upcoming year 2020. We identified 268 articles reporting the prevalence of childhood asthma, 
but only these (n=222) defining asthma cases by following one of the five versions of Chinese 
diagnostic criteria were finally included for analysis. As these versions of Chinese criteria were 
all quite similar, therefore we did not consider that these minor difference would substantially 
distort the comparison of asthma prevalence between studies. Additionally, a small number of 
studies followed the protocol of The International Study of Asthma and Allergies in Childhood 
(ISAAC) and most of them were published prior to 2010 [5]. Studies based on ISAAC protocol 
relied on self-reported or parental reports of asthma [5], while the Chinese diagnostic criteria 
relied on the physician to evaluate the collected information of each asthma potential case and 
make sure that a set of necessary of criteria were fulfilled [13]. The differences described above 
point towards the need for reasonable similar disease definitions and data collection methods 
in order to be able to synthesize prevalence between studies. Given the sample size was large 
for articles based on Chinese diagnostic criteria, we therefore restrict our analysis to the 
Chinese diagnostic criteria only. 
With following the Chinese diagnostic criteria, we estimated an overall prevalence of 2.12% 
for children aged 0-14 years, corresponding to 5.16 million children living with asthma in 2010. 
Our estimates were generally consistent with these reported in two published meta-analyses. 
In 2012, Yangzong et al reviewed the epidemiology studies of childhood asthma in China, and 
identified 12 studies followed the ISAAC protocol whereas 62 studies followed the Chinese 
diagnostic criteria [17]. They reported generally low prevalence following both criteria, 
whereas time trends in the prevalence were not summarized. Another meta-analysis of 117 
studies that were published between 1988 and 2014 and followed the Chinese diagnostic 
criteria with a total sample size of 2,678,696 was conducted subsequently, and reported an 
overall asthma prevalence of 2.11% in children [18]. Their estimate is quite similar to ours. 
Our study observed an overall increasing trend of childhood asthma prevalence during the two 
past decades, from 0.91% in 1990, to 1.54% in 2000, to 2.12% in 2010, and indicated the 
prevalence of asthma in Chinese children having increased by almost 50% every 10 years. Our 
estimates were much in line with the increasing trend of asthma prevalence globally, though 
they are much lower than the current prevalence in many other countries, especially in 
developed countries, such as Austria (11.3%), United States (8.69%), United Kingdom (15.4%) 
and Canada (13%) [2,19]. When taking into account the facts that China possessed the highest 




population in the world, the disease burden attributed to asthma could be as heavy as these high 
prevalent countries. 
Furthermore, the prevalence had more often been assessed in urban than in rural areas, making 
it difficult to some extent to compare the difference between urban and rural areas. Most of the 
surveys had been conducted in large and modern cities, like Shanghai and Beijing. With a 
wealth of data from urban areas, the prevalence of childhood asthma was higher than that in 
rural areas. In Beijing, the total prevalence of asthma in children aged below 14 years in rural 
areas (1.3%) was much lower than that in urban areas (3.7%) [9]. These findings are consistent 
with the idea that the degree of modernization or westernization is related to high prevalence 
of asthma [20]. In China, rural areas are generally with less or lower–quality health resources 
and worse health outcomes in comparison to urban areas [21,22]. This urban-rural disparity of 
asthma prevalence may be associated with prevalent indoor and outdoor air pollution resulting 
from multifarious interior decoration or heavy traffics in urban areas [23,24]. In addition, lower 
socioeconomic status and lower health resource quality in rural areas may also have contributed 
to the under-diagnosis of asthma [25]. 
As expected, asthma prevalence retains to be higher in boys than in girls (3.69% versus 2.25% 
in urban areas).  When comparing to adults, the asthma prevalence is higher in women than in 
men, indicating a switch during puberty [26]. This pattern has raised several hypotheses to 
explain the sex difference, such as effects of sex hormones, airway calibre, and differences in 
exposure or diagnosis [27]. The higher prevalence in boys could be partly due to their smaller 
airway relative to lung size compared with young girls, and this patter reverses during 
adolescence [28]. Other possible explanations include hormonal changes and sex-specific 
differences in genetic susceptibility [29]. In particular, sex hormones are indicated to play an 
important role in the development and outcome of the allergic immune response, in particular 
asthma, as outlined by many studies [27,29,30]. A better understanding of precisely how sex 
hormones change the immune system’s response to allergens has the potential to help us tailor 
asthma therapy more specifically. 
In view of the relation between asthma prevalence and age, our study confirms that children 
aged 5-9 years have the highest prevalence (2.65%). Children in this age group always have a 
weak immune system and low self-management abilities, thus they are vulnerable to the upper 
respiratory infection, which is thought to be one of the main contributors of childhood asthma 
[31]. A similar condition was observed in the meta-analysis reported by Guo et al [18]. Along 
with the increase of age, asthma prevalence decreases at 10-14 years. This decrease might be 
attributed to the strengthened self-management abilities and stronger immunity. Additionally, 
the reported prevalence for children under age five should be interpreted with caution. Special 
challenges in asthma diagnosis must be taken into account, as the diagnosis of asthma in 
younger children has to be largely based on clinical judgment and an assessment of symptoms 
and physical findings [32]. In this case, a confident diagnosis of asthma can be difficult because 
episodic respiratory symptoms such as wheezing and cough are also common in children 
without asthma in this age group. Importantly, it should be realised that reliable quantitative 




scoring system is also recently initiated in China to establish a diagnostic system for asthma in 
young children and babies [34]. Promoting the physician’s knowledge and adherence to the 
updated Chinese guideline and recommendations would considerably improve the diagnosis 
and thus ensure an accurate estimate of the disease burden of asthma in younger children in 
China. 
Our study also has several potential limitations. First, significant heterogeneity was seen 
between the included studies. This could be partly due to the regional difference, given that 
China is a diverse country with highly varied culture, levels of development and demographic 
characteristics. It could also be attributed to the increasingly recognized heterogeneity of 
asthma, as there is no gold-standard diagnostic test. Although only studies that adopted the 
Chinese diagnostic criteria were included, in order to reduce the methodological variability, 
heterogeneity may still exist because of the differences among investigators in operating 
protocols, levels of training, adherence to guidelines and variations in the implementation of 
guidelines. Moreover, there is increasing community awareness of asthma, leading to changing 
diagnostic habits and international classification had also changed over time, all leading to 
difficulties determining the reality and accuracy of reported trends. Another possible cause for 
concern is that the results of meta-regression only took into account a limited set of covariates 
(ie, sex, age, year and urbanicity) because these were the only covariates that were broadly 
available. The scarcity of studies adopting unified definitions of other covariates limited our 
ability to explore more possible effects. 
Conclusions 
In conclusion, results from this study have shown that childhood asthma is increasingly 
prevalent in China. Asthma is more frequent in boys and in rural areas. Further analysis from 
an epidemiological perspective will remain to be required to explore the temporal distribution 
of asthma prevalence in Chinese children. The detailed and systematic estimates of asthma 
prevalence and the number of cases in this study constitute the best currently available basis 
for policymaking, planning, and allocation of health and welfare resources related to the burden 
of childhood asthma in China. Optimal intervention delivery - both in primary and secondary 
prevention and treatment - is urgently needed to counter this growing trend. 
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Figure 1. Flow diagram of systematic review process. 
Figure 2. Age-specific prevalence of asthma in Chinese children based on the data points from 
the included studies. 
The spot sizes were scaled according to the study sample sizes. 
Figure 3. Age-, sex- and setting-specific prevalence of asthma in Chinese children in the years 
1990, 2000, 2010 and 2020, with 95% confidence intervals. 
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Table 1. Main characteristics of the included articles (n=222) 
Characteristic Number of articles 
(%) 
Year published: 
1990-1999 31 (14.0) 
2000-2009 79 (35.6) 
2010-2016 112 (50.5) 
Setting: 




Rural 11 (5.0) 
Mixed 69 (31.1) 
Sample size: 
100-5,000 30 (13.5) 
5,001–10,000 43 (19.4) 
10,001–20,000 97 (43.7) 





Table 2. Estimated sex- and setting-specific prevalence of and numbers of children with asthma in China in 2010, by broad age group 
 
Age group Prevalence of asthma (%) Children with asthma (millions) 
Urban Rural Overall Urban Rural Overall 
Boy Girl Boy Girl Overall Boy Girl Boy Girl Overall 
0-4 years 3.99 (3.56-4.47) 2.23 (1.98-2.59) 1.46 (0.99-2.09) 0.88 (0.59-1.27) 2.26 (1.93-2.65) 0.72 (0.65-0.81) 0.38 (0.34-0.43) 0.50 (0.40-0.62) 0.26 (0.21-0.32) 1.87 (1.60-2.19) 
5-9 years 4.57 (4.14-5.18) 2.93 (2.62-3.40) 1.95 (1.34-2.82) 1.17 (0.79-1.71) 2.65 (2.31-3.12) 0.83 (0.76-0.94) 0.45 (0.40-0.51) 0.53 (0.44-0.66) 0.28 (0.23-0.35) 2.09 (1.83-2.47) 
10-14 years 2.57 (2.28-2.97) 1.63 (1.42-1.91) 1.08 (0.72-1.59) 0.64 (0.43-0.94) 1.48 (1.26-1.78) 0.49 (0.43-0.56) 0.26 (0.23-0.30) 0.29 (0.24-0.37) 0.16 (0.13-0.20) 1.20 (1.03-1.44) 
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